Paloma Partners’s GeneDx Holdings WGS Stock Holding History

Paloma Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,633	Closed	-$876K	–	1095
2024 Q3	$876K	Hold	20,633	–	–	0.02%	454
2024 Q2	$539K	Hold	20,633	–	–	0.02%	712
2024 Q1	$188K	Hold	20,633	–	–	0.01%	609
2023 Q4	$56.7K	Hold	20,633	–	–	﹤0.01%	656
2023 Q3	$75.1K	Hold	20,633	–	–	﹤0.01%	627
2023 Q2	$123K	Buy	20,633 +20,008	+3,201%	+$158K	﹤0.01%	639
2023 Q1	$7.53K	Hold	625	–	–	﹤0.01%	730
2022 Q4	$335	Hold	625	–	–	﹤0.01%	883
2022 Q3	$18K	Hold	625	–	–	﹤0.01%	932
2022 Q2	$26K	Hold	625	–	–	﹤0.01%	1044
2022 Q1	$63K	Hold	625	–	–	﹤0.01%	1652
2021 Q4	$92K	Buy	+625	New	+$140K	﹤0.01%	1781

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Paloma Partners's WGS Position: Q1 2022 in Review

Paloma Partners sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 1,403 shares — an estimated $156K sold.

Paloma Partners first reported a position in WGS in Q3 2021 and held it in 2 quarters. The position peaked at $220K in Q3 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

Paloma Partners reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
Paloma Partners sold 1,403 GeneDx Holdings shares in Q1 2022, an estimated $156K.
Paloma Partners first reported a position in GeneDx Holdings in Q3 2021 and held it in 2 quarters.
Paloma Partners's GeneDx Holdings position peaked at $220K in Q3 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.